03/19/2024
6:09 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:45 AM | PFIZER INC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/14/2024
8:08 PM | Hydra LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/14/2024
7:51 PM | Blue Owl Capital Holdings LP (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/09/2024
4:24 PM | Blackstone Holdings II L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
02/07/2024
1:11 PM | BML Investment Partners, L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G/A | |
|
01/31/2024
3:26 PM | MCDADE MARK (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
8:20 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 424B5 | |
01/08/2024
8:19 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
7:27 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
7:25 AM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
5:14 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:15 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
3:30 PM | Hydra LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
10/30/2023
4:16 PM | Longitude Capital Partners III, LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13D/A | |
10/30/2023
3:15 PM | Qiming U.S. Healthcare GP II, LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13D/A | |
10/27/2023
4:43 PM | Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
4:17 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
4:00 PM | KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
4:34 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:46 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:25 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:26 PM | MCDADE MARK (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:29 PM | MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:30 PM | Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:31 PM | Srivastava Sapna (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:33 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:18 PM | Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:20 PM | CHYUNG YUNG H. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:21 PM | Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:23 PM | Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
7:24 PM | KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
5:27 PM | Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:27 PM | Chester Cariad (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:28 PM | CHYUNG YUNG H. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:29 PM | Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:30 PM | Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:31 PM | KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:31 PM | Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:32 PM | MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
10/23/2023
5:33 PM | Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2023
5:34 PM | Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/20/2023
8:23 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/19/2023
8:11 PM | Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
3:32 PM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
10/10/2023
3:30 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K/A | |
10/06/2023
4:26 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:27 PM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
10/06/2023
4:30 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:21 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
7:24 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
09/15/2023
5:31 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 424B3 | |
09/14/2023
11:15 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form EFFECT | |
09/13/2023
3:28 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4/A | |
09/13/2023
8:13 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
8:14 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
09/11/2023
3:47 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4/A | |
08/28/2023
6:38 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
08/25/2023
3:34 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4/A | |
08/14/2023
6:53 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2023
6:57 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
07/06/2023
4:19 PM | Requadt Scott (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
4:20 PM | Fenton Mary Kay (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:32 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
07/05/2023
4:10 PM | Requadt Scott (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
3:52 PM | Fenton Mary Kay (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
8:10 AM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
8:12 AM | Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 425 | |
06/14/2023
5:56 PM | Agarwala Sandip (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:58 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:59 PM | MACKAY GEOFFREY (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
5:59 PM | MCDADE MARK (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:00 PM | Nader Francois (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:01 PM | Shah Gaurav (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:02 PM | Smith Karen L. (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:03 PM | Srivastava Sapna (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:41 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
5:24 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:21 PM | Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2023
3:07 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form DEF 14A | |
04/28/2023
3:08 PM | Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
| Form DEFA14A | |
04/27/2023
9:55 AM | BML Investment Partners, L.P. (Filed by)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
| Form SC 13G | |
